By Joe Mont2016-03-08T21:00:00
With proxy season just around the corner, the annual tradition of assessing the mood of investors has begun. On tap, experts say, are demands for improved transparency and communication, better disclosures, and a continuing scrutiny of directors, including how (and how much) they and their C-suite cohorts are compensated. “We ...
2016-11-01T10:30:00Z By Joe Mont
Joe Mont reports on the SEC’s proposal for universal proxy cards. Meant to improve board composition, some fear they might create shareholder chaos.
2016-05-10T13:45:00Z By Jaclyn Jaeger
A year ago, Theranos was a Silicon Valley health tech “unicorn” praised for breakthrough advancements in blood testing. Now it’s under civil and criminal investigation for defrauding investors. The role Theranos’ board has played in this is already shaping up to be a pointed object lesson for board best practices ...
2025-09-05T21:03:00Z By Aly McDevitt
Nestlé dismissed its CEO over an undisclosed relationship with a subordinate, a clear breach of the company’s code of business conduct. The dismissal underscores that no one is exempt from compliance obligations, even top leadership.
Site powered by Webvision Cloud